Literature DB >> 23086933

β-Catenin and peroxisome proliferator-activated receptor-δ coordinate dynamic chromatin loops for the transcription of vascular endothelial growth factor A gene in colon cancer cells.

Injoo Hwang1, Jeeho Kim, Sunjoo Jeong.   

Abstract

Vascular endothelial growth factor A (VEGFA) mRNA is regulated by β-catenin and peroxisome proliferator activated receptor δ (PPAR-δ) activation in colon cancer cells, but the detailed mechanism remains to be elucidated. As chromatin loops are generally hubs for transcription factors, we tested here whether β-catenin could modulate chromatin looping near the VEGFA gene and play any important role for PPAR-δ activated VEGFA transcription. First, we identified the far upstream site as an important site for VEGFA transcription by luciferase assay and chromatin immunoprecipitation in colorectal carcinoma HCT116 cells. Chromatin conformation capture analysis also revealed the chromatin loops formed by the β-catenin bindings on these sites near the VEGFA gene. Dynamic association and dissociation of β-catenin/TCF-4/PPAR-δ on the far upstream site and β-catenin/NF-κB p65 on the downstream site were also detected depending on PPAR-δ activation. Interestingly, β-catenin-mediated chromatin loops were relieved by PPAR-δ activation, suggesting a regulatory role of β-catenin for VEGFA transcription. Based on these data, we propose a model for PPAR-δ-activated VEGFA transcription that relies on β-catenin-mediated chromatin looping as a prerequisite for the activation. Our findings could extend to other β-catenin regulated target genes and could provide a general mechanism and novel paradigm for β-catenin-mediated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086933      PMCID: PMC3510834          DOI: 10.1074/jbc.M112.377739

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  Control of eukaryotic gene expression: gene loops and transcriptional memory.

Authors:  Michael Hampsey; Badri Nath Singh; Athar Ansari; Jean-Philippe Lainé; Shankarling Krishnamurthy
Journal:  Adv Enzyme Regul       Date:  2010-10-29

2.  Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells.

Authors:  Pantelis Hatzis; Laurens G van der Flier; Marc A van Driel; Victor Guryev; Fiona Nielsen; Sergei Denissov; Isaäc J Nijman; Jan Koster; Evan E Santo; Willem Welboren; Rogier Versteeg; Edwin Cuppen; Marc van de Wetering; Hans Clevers; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

3.  Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.

Authors:  Clemens Röhrl; Ulrike Kaindl; Inga Koneczny; Xenia Hudec; David M Baron; Jürgen S König; Brigitte Marian
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-11       Impact factor: 4.553

Review 4.  Peroxisome proliferator-activated receptors and inflammation.

Authors:  Leonardo A Moraes; Laura Piqueras; David Bishop-Bailey
Journal:  Pharmacol Ther       Date:  2005-09-15       Impact factor: 12.310

5.  A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.

Authors:  Shlomo Handeli; Julian A Simon
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

Review 6.  Peroxisome proliferator-activated receptor delta and gastric cancer (Review).

Authors:  Chung W Wu; Jun Yu; Joseph J Y Sung
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

Review 7.  Wnt signaling in the vasculature.

Authors:  A M Goodwin; P A D'Amore
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

8.  Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells.

Authors:  Natalia A Ignatenko; Naveen Babbar; Dipti Mehta; Robert A Casero; Eugene W Gerner
Journal:  Mol Carcinog       Date:  2004-02       Impact factor: 4.784

9.  Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Authors:  Xiangsheng Zuo; Zhanglong Peng; Micheline J Moussalli; Jeffrey S Morris; Russell R Broaddus; Susan M Fischer; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

Review 10.  Long-range control of gene expression: emerging mechanisms and disruption in disease.

Authors:  Dirk A Kleinjan; Veronica van Heyningen
Journal:  Am J Hum Genet       Date:  2004-11-17       Impact factor: 11.025

View more
  7 in total

Review 1.  Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.

Authors:  Greta M P Giordano Attianese; Béatrice Desvergne
Journal:  Nucl Recept Signal       Date:  2015-04-27

2.  Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.

Authors:  Padmamalini Thulasiraman; Daniel J McAndrews; Imran Q Mohiudddin
Journal:  BMC Cancer       Date:  2014-09-27       Impact factor: 4.430

Review 3.  Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy.

Authors:  Qian Gou; Xin Gong; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Oncotarget       Date:  2017-07-27

Review 4.  Wnt/β-catenin Pathway-Mediated PPARδ Expression during Embryonic Development Differentiation and Disease.

Authors:  Tabinda Sidrat; Zia-Ur Rehman; Myeong-Don Joo; Kyeong-Lim Lee; Il-Keun Kong
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

5.  Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.

Authors:  Jinjoo Park; Sunjoo Jeong
Journal:  Oncotarget       Date:  2015-10-27

Review 6.  PPARβ/δ: Linking Metabolism to Regeneration.

Authors:  Ajit Magadum; Felix B Engel
Journal:  Int J Mol Sci       Date:  2018-07-10       Impact factor: 5.923

7.  Role of Wnt Signaling During In-Vitro Bovine Blastocyst Development and Maturation in Synergism with PPARδ Signaling.

Authors:  Tabinda Sidrat; Abdul Aziz Khan; Muhammad Idrees; Myeong-Don Joo; Lianguang Xu; Kyeong-Lim Lee; Il-Keun Kong
Journal:  Cells       Date:  2020-04-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.